Social anxiety disorder is where the modern CBD anxiety story began. In 2011, Mateus Bergamaschi and colleagues gave 600mg of cannabidiol to a group of people with social phobia who had never been treated, then put them through a simulated public speaking test, the situation that defines the disorder. The CBD group's anxiety during the speech dropped to roughly the level of healthy controls who did not have social anxiety at all. In the same period, Crippa 2011 used brain imaging to show that CBD changed activity in the limbic and paralimbic regions that process threat, giving the behavioural result a neural correlate. These two studies are the foundation the entire CBD-for-anxiety market was built on, and they were run in social anxiety, not anxiety in general.
That history makes social anxiety the strongest case for CBD in the anxiety cluster, and it also makes it the clearest illustration of the split between the two main cannabinoids. The evidence here is CBD-specific. CBD is a partial agonist at the 5HT-1A serotonin receptor, the same target the anti-anxiety drug buspirone acts on, and it does not produce intoxication. THC does the opposite of what social anxiety needs. Its biphasic curve means that above a low threshold it provokes anxiety, and the Childs 2017 work showed a standard-sized dose increasing distress in a social stress test. For a condition built around the fear of being watched and judged, THC-induced self-consciousness and a racing heart are close to the last thing you want to introduce before a social situation.
This page treats social anxiety as its own condition inside the Anxiety and Mood cluster, distinct from generalized anxiety in an important way: the fear here is tied to social scrutiny and performance rather than free-floating worry, and that shapes both the evidence and the dosing strategy. The page covers what the trials actually tested, the growing case for daily rather than as-needed dosing, why the protocol is CBD-dominant to the point of leaving THC out for most people, and where cannabis sits relative to the therapy that remains the first-line treatment.
What the research actually shows about CBD for social anxiety
The social anxiety evidence is the strongest in the anxiety literature, and it still has real limits worth stating. Bergamaschi 2011 is the anchor: a double-blind, placebo-controlled trial in which 600mg of CBD given to treatment-naive social phobia patients before a simulated public speaking test reduced their anxiety, cognitive impairment, and discomfort during the speech, bringing their responses close to those of healthy controls. Crippa 2011 gave 400mg of CBD to people with generalized social anxiety disorder and used SPECT imaging to show corresponding changes in limbic and paralimbic blood flow, which made the effect difficult to write off as placebo. Both studies are small, both are single-dose, and both test the acute public speaking model rather than the broader experience of living with the disorder.
That single-dose design was the standard for years, and it shaped the popular picture of CBD as something taken an hour before a stressful event. The more recent work is what makes social anxiety interesting again, because it questions that picture. Masataka 2019 gave 300mg of CBD daily for four weeks to teenagers with social anxiety disorder and found significant reductions in social anxiety symptoms on standard rating scales, a sustained-dosing result in the exact population where social anxiety typically first appears. Gournay 2023 sharpened the point: in a trial designed to compare acute against repeated dosing, a single dose of CBD did nothing measurable for anxiety, while 300mg daily across two weeks did reduce it. The implication runs against the event-by-event marketing. For a chronic condition, the daily approach has the better evidence.
The dose picture carries the same inverted-U caution seen across the anxiety cluster. Linares 2019 tested 150mg, 300mg, and 600mg before a public speaking test and found that only 300mg reduced anxiety, with the lower and higher doses no better than placebo. More CBD is not reliably better, and the effective window sits far above what edibles contain and below the point where the effect fades again. The 2024 systematic review of eleven randomized CBD anxiety trials placed social anxiety among the better-supported indications while reaching the field-wide conclusion: the signal is real, the trials are small, and larger studies with sustained dosing are needed. One of those larger studies, a completed 2025 NYU trial built to identify the biological signature of CBD's effect in social anxiety disorder, reflects where the research is now heading.
What none of this evidence supports is THC. No trial has shown THC helping social anxiety, and the mechanism points the wrong way. The honest summary is that CBD has a genuine, if still preliminary, evidence base in social anxiety, that the base is strongest for sustained daily dosing at doses well above edible strength, and that the cannabinoid doing the work is the non-intoxicating one.
Why THC is the wrong tool for this condition in particular
Every anxiety page in this cluster warns about THC's biphasic curve, and social anxiety is where the warning is sharpest. The reason is the nature of the fear. Social anxiety disorder is defined by an intense fear of scrutiny and negative evaluation, often with prominent physical symptoms: racing heart, sweating, trembling, blushing, the sense that everyone can see the distress. THC at more than a low dose tends to produce racing heart, heightened self-consciousness, and a fear that others are noticing, which is a near-perfect match for the symptoms the person is already trying to escape.
The setting compounds the risk. Someone reaches for cannabis before a party, a presentation, or a date, exactly the high-stakes social situations where a bad reaction is most exposing. A person who takes a standard 10mg edible before an event to calm their nerves, and instead climbs the anxiogenic side of the curve 75 minutes in, is now experiencing amplified social anxiety in the middle of the situation they were dreading, with hours to go before it fades and no way to leave the effect behind. The edible format, slow to start and impossible to take back, is especially poorly matched to social anxiety's time-limited, high-pressure triggers.
This is why the protocol below is CBD-dominant to the point of leaving THC out for most people. The reasoning is not caution for its own sake: the one cannabinoid with evidence here is CBD, and the other one reproduces the symptoms of the disorder. The contrast with the Pain cluster is instructive: for arthritis the human CBD trials were null and the evidence favoured THC, while for social anxiety the human CBD trials are the whole positive story and THC is close to contraindicated. The cannabinoid that fits a condition follows that condition's biology, and these two conditions point in opposite directions.
The protocol
Use CBD, use it daily, and treat it as a sustained intervention rather than a pre-event rescue. Start at 25 to 50mg of CBD in the morning or evening, with the honest caveat that this sits below the researched doses and is a starting point rather than a therapeutic target. The trials that worked used 300mg, and a person serious about testing CBD for social anxiety on the terms the evidence supports is looking at building toward roughly 300mg daily using tinctures or capsules, since reaching that with gummies is impractical and expensive. Give any dose at least two weeks before judging it, because the sustained-dosing studies found the benefit emerging over weeks rather than in a single session.
Keep THC out, or nearly so. For most people with social anxiety, a CBD-only product is the right choice, and the default should be zero THC. If someone is already an experienced cannabis user and wants a small THC component, the ceiling is very low, on the order of 2.5mg, kept well below the threshold where THC turns anxiogenic and always paired with a much larger CBD dose that blunts THC's effect at the CB1 receptor. Anyone who has had a panic-like or intensely self-conscious reaction to THC before should take that history seriously and stay CBD-only. There is no version of this condition where a large THC dose is the right call.
Do not build the plan around dosing before feared events. The intuitive approach, taking something an hour before the party, is the one the newer evidence undercuts, since acute dosing performed worst in the head-to-head test. Event-triggered dosing also feeds the trap the condition runs on: using a substance to get through feared situations reinforces the belief that those situations cannot be faced without it, which is the opposite of what recovery requires. A steady daily CBD regimen, used as a background support while the person does the harder work of facing social situations, ideally with a therapist, fits both the evidence and the psychology of the disorder better than the pre-event model.
Watch for the avoidance trap above all. The measure of whether cannabis is helping social anxiety is whether the person is engaging with more of the situations they used to avoid, not whether they feel calmer while continuing to avoid them. Calm achieved through continued avoidance is the disorder winning quietly. If CBD helps someone enter situations they would otherwise skip, it is doing something useful. If it becomes a condition they need met before any social contact, it has become part of the problem.
Where cannabis is the wrong tool for social anxiety
A few situations deserve naming directly. Anyone with a personal or family history of psychosis or schizophrenia should avoid THC entirely; CBD alone does not carry the same concern and has been studied in high-risk groups with a different profile. Anyone who experiences panic attacks in social settings should be especially wary of THC, because a THC-driven anxiety surge can be indistinguishable from a panic attack while lasting far longer, and going through that in public is precisely the feared outcome that can deepen the disorder.
And anyone whose social life has come to depend on using cannabis to manage is in the pattern this page keeps circling. Using a substance to tolerate social situations can slide into needing it for all of them, and cannabis use disorder is more common among people using it to cope with anxiety. The signals are the familiar two: needing more over time to get the same effect, and feeling unable to face social situations without it. Both mean the tool has started reinforcing the fear it was picked up to ease. Social anxiety is genuinely treatable, and the treatments that resolve it rather than merely muffle it are therapy and, where needed, medication.